List of insiders holdings for Dicerna Pharmaceuticals Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Domain Partners VIII L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Halak Brian K 10% Owner |
2018-11-05 10:30:46 | 2,919,056 0 |
2,919,056 | Form 13D |
| 2 | RA CAPITAL MANAGEMENT LLC RA Capital Healthcare Fund LP 10% Owner |
2018-11-06 19:30:59 | 2,814,589 0 |
2,814,589 | Form 13D |
| 3 | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund L.P. BCIP Life Sciences Associates LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner |
2020-12-14 17:25:51 | 2,786,247 0 |
2,786,247 | Form 13D |
| 4 | Skyline Venture Partners V LP Skyline Venture Management V LLC Freund John Gordon KANEKO YASUNORI former 10% holder |
2015-02-24 20:52:12 | 0 1,719,671 |
1,719,671 | Form 4 |
| 5 | GREEN JOHN B Chief Financial Officer |
2020-04-22 20:00:40 | 205,796 0 |
205,796 | Form 4 |
| 6 | ROSSKAMP RALF Chief Medical Officer |
2020-01-10 20:02:06 | 108,100 0 |
108,100 | Form 4 |
| 7 | Dentzer James E Chief Financial Officer |
2015-01-13 20:39:37 | 75,000 0 |
75,000 | Form 4 |
| 8 | Bhargava Pankaj Chief Medical Officer |
2016-01-12 16:05:30 | 75,000 0 |
75,000 | Form 4 |
| 9 | Ashburn Theodore See Remarks |
2016-01-12 16:07:11 | 75,000 0 |
75,000 | Form 4 |
| 10 | SCHOEMAKER KATHLEEN K 10% Owner |
2014-02-04 15:50:36 | 0 34,201 |
34,201 | Form 4 |
| 11 | MADDEN DAVID Director |
2018-06-25 21:02:17 | 33,000 0 |
33,000 | Form 4 |
| 12 | DP VIII Associates L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Halak Brian K 10% Owner |
2017-12-20 16:51:02 | 25,730 0 |
25,730 | Form 4 |
| 13 | Wise Bart W SVP, Legal Affairs |
2018-06-26 21:15:58 | 25,000 0 |
25,000 | Form 4 |
| 14 | LANGER DENNIS Director |
2019-06-21 20:01:47 | 25,000 0 |
25,000 | Form 4 |
| 15 | PEACOCK BRUCE Director |
2017-07-20 17:00:40 | 25,000 0 |
25,000 | Form 4 |
| 16 | Paglia Regina M. Chief Human Resources Officer |
2021-07-08 21:32:39 | 21,265 0 |
21,265 | Form 4 |
| 17 | Halak Brian K Director |
2018-11-06 16:16:07 | 0 19,150 |
19,150 | Form 4 |
| 18 | Miles Vincent J Director |
2014-06-23 14:08:00 | 15,000 0 |
15,000 | Form 4 |
| 19 | Protopapas Anna Director |
2021-06-07 21:34:18 | 3,333 0 |
3,333 | Form 4 |
| 20 | BROOKSIDE CAPITAL MANAGEMENT LLC BROOKSIDE CAPITAL INVESTORS L P BROOKSIDE CAPITAL PARTNERS FUND LP Brookside Capital Investors II L.P. Brookside Capital Trading Fund L.P. 10% Owner |
2015-02-17 15:31:59 | 23 0 |
23 | Form 13G |
| 21 | FAMBROUGH DOUGLAS Chief Executive Officer |
2021-12-29 16:19:54 | 0 0 |
0 | Form 4 |
| 22 | KOZIN MARC D Director |
2021-12-29 16:21:05 | 0 0 |
0 | Form 4 |
| 23 | HOFFMAN STEPHEN J Director |
2021-12-29 16:20:44 | 0 0 |
0 | Form 4 |
| 24 | GRAY PATRICK M. Director |
2021-12-29 16:20:28 | 0 0 |
0 | Form 4 |
| 25 | Kolchinsky Peter Director |
2019-12-02 16:30:39 | 0 0 |
0 | Form 4 |
| 26 | Smith Cynthia Director |
2021-12-29 16:21:51 | 0 0 |
0 | Form 4 |
| 27 | Pagan Douglas W. Chief Financial Officer |
2021-12-29 16:21:31 | 0 0 |
0 | Form 4 |
| 28 | Weissman James B Chief Operating Officer & EVP |
2021-12-29 16:22:10 | 0 0 |
0 | Form 4 |
| 29 | Zeng Ling Chief Legal Officer & Sec'y |
2021-12-29 16:22:27 | 0 0 |
0 | Form 4 |
| 30 | Koppel Adam Director |
2021-12-29 16:43:55 | 0 0 |
0 | Form 4 |
| 31 | Freed Martin I Director |
2021-12-29 16:20:11 | 0 0 |
0 | Form 4 |
| 32 | Doberstein Stephen K Director |
2021-12-29 16:19:29 | 0 0 |
0 | Form 4 |
| 33 | Ciappenelli Robert D. Chief Strategy Officer |
2021-12-29 16:19:06 | 0 0 |
0 | Form 4 |
| 34 | BUCHI J KEVIN Director |
2021-12-29 16:18:42 | 0 0 |
0 | Form 4 |
| 35 | Brown Bob D Chief Scientific Ofr., EVP R&D |
2021-12-29 16:18:23 | 0 0 |
0 | Form 4 |
| 36 | Aradhye Shreeram EVP & Chief Medical Officer |
2021-12-29 16:17:59 | 0 0 |
0 | Form 4 |
| 37 | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund L.P. Deerfield Private Design Fund II L.P. Deerfield Private Design International II L.P. Possible Member of 10% Group 10% Owner |
2014-12-19 15:47:30 | 0 0 |
0 | Form 13G |
| 38 | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund L.P. Deerfield Special Situations International Master Fund L.P. Deerfield Private Design Fund II L.P. Deerfield Private Design International II L.P. Possible Member of 10% Group 10% Owner |
2014-12-19 15:47:30 | 0 0 |
0 | Form 13G |
| 39 | Flynn James E Deerfield Mgmt L.P. Deerfield Special Situations Fund L.P. Deerfield Special Situations International Master Fund L.P. Deerfield Private Design Fund II L.P. DEERFIELD MANAGEMENT CO Deerfield Private Design International II Ltd. Possible Members of 10% Group 10% Owner |
2014-12-19 15:47:30 | 0 0 |
0 | Form 13G |